학술논문

P14 OCULAR TOXICITY IN TRANSPLANT INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH BELANTAMAB MAFODOTIN, LENALIDOMIDE AND DEXAMETHASONE IN A PHASE 1/2 TRIAL
Document Type
article
Source
HemaSphere, Vol 7, Iss S2, Pp 17-18 (2023)
Subject
Diseases of the blood and blood-forming organs
RC633-647.5
Language
English
ISSN
2572-9241